NRX Pharmaceuticals, Inc. (NRXP) stock
NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.80+0.35 (+14.29%)
Close on Nov 18, 2026Market cap $121.23MP/E –Yield –
NRX Pharmaceuticals profit margin
Profit margin (net margin) is net income as a percentage of revenue.
NRX Pharmaceuticals's profit margin for the twelve months ending Jun 30, 2026 was -691.8%. For fiscal 2025 it was -2336.5%.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2336.5% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -1500.5% | – |
| Q1 FY2026 | Mar 31, 2026 | -133.9% | – |
| Q4 FY2025 | Dec 31, 2025 | 36.6% | – |
| Q3 FY2025 | Sep 30, 2025 | -2433.9% | – |
See a number that looks wrong?